[1]
Khare, A., Mandloi, V., Shrivastava, A., Shrivastava, A.K., Wadagbalkar, P. and Kumar, A. 2019. Impact of oral palonosetron in improving quality of life as compared to other oral 5-HT3 antagonists in delayed chemotherapy induced nausea and vomiting in patients of head and neck cancer. International Journal of Basic & Clinical Pharmacology. 8, 3 (Feb. 2019), 493–496. DOI:https://doi.org/10.18203/2319-2003.ijbcp20190653.